Long-term efficacy and safety of rabeprazole in patients taking low-dose aspirin with a history of peptic ulcers: a phase 2/3, randomized, parallel-group, multicenter, extension clinical trial

A 24-week, double-blind, clinical trial of rabeprazole for the prevention of recurrent peptic ulcers caused by low-dose aspirin (LDA) has been reported, but trials for longer than 24 weeks have not been reported. The aim of this study is to assess the long-term efficacy and safety of rabeprazole for...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujishiro, Mitsuhiro, Higuchi, Kazuhide, Kato, Mototsugu, Kinoshita, Yoshikazu, Iwakiri, Ryuichi, Watanabe, Toshio, Takeuchi, Toshihisa, Sugisaki, Nobuyuki, Okada, Yasushi, Ogawa, Hisao, Arakawa, Tetsuo, Fujimoto, Kazuma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: the Society for Free Radical Research Japan 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4454079/
https://www.ncbi.nlm.nih.gov/pubmed/26060354
http://dx.doi.org/10.3164/jcbn.15-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4454079/
https://www.ncbi.nlm.nih.gov/pubmed/26060354
http://dx.doi.org/10.3164/jcbn.15-1

Ejemplares similares